Johnson & Johnson (JNJ)

125.85
NYSE : Health Technology
Prev Close 125.94
Day Low/High 125.12 / 126.14
52 Wk Low/High 118.62 / 148.32
Avg Volume 6.40M
Exchange NYSE
Shares Outstanding 2.68B
Market Cap 337.79B
EPS 0.50
P/E Ratio 273.78
Div & Yield 3.60 (2.68%)

Latest News

Rewind: Why Jim Cramer Is Bullish on Johnson & Johnson Shares

Rewind: Why Jim Cramer Is Bullish on Johnson & Johnson Shares

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer is bullish on Johnson & Johnson shares.

Market Refuses To Go Lower: Cramer's 'Mad Money' Recap (Tuesday 7/17/18)

Market Refuses To Go Lower: Cramer's 'Mad Money' Recap (Tuesday 7/17/18)

Investors have never gone wrong buying Netflix on the dips. Jim Cramer tells you what to make of the 'FANG Musketeers.'

J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer

J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer

One lawyer likens the case to Big Tobacco's fight for decades against lung cancer sufferers who smoked.

Markets Close Higher After Fed Chair Powell's Capitol Hill Testimony

Markets Close Higher After Fed Chair Powell's Capitol Hill Testimony

All three major indices reversed early losses to end higher Tuesday.

Jim Cramer: A Pretty Wild Rally In Three Oppositional Groups

Jim Cramer: A Pretty Wild Rally In Three Oppositional Groups

How can this be? Let's take a look at the camps so we can figure it out.

Jim Cramer on Johnson & Johnson's Pharmaceuticals Sales Growth

Jim Cramer on Johnson & Johnson's Pharmaceuticals Sales Growth

When investors review a drug company, pay close attention to its pharma performance, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Jim Cramer on Netflix, Goldman Sachs, Bank of America and Johnson & Johnson

Jim Cramer on Netflix, Goldman Sachs, Bank of America and Johnson & Johnson

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's trending stocks from the floor of the New York Stock Exchange.

Netflix, Amazon, Jerome Powell, Walmart and Microsoft - 5 Things You Must Know

Netflix, Amazon, Jerome Powell, Walmart and Microsoft - 5 Things You Must Know

U.S. stock futures are lower Tuesday ahead of Federal Reserve Chairman Jerome Powell's first testimony before Congress; Netflix slumps as it misses estimates on subscribers growth; Amazon's Prime Day has a giant hiccup.

Highs (and Lows) of FANG Trading: Market Recon

Highs (and Lows) of FANG Trading: Market Recon

My Netflix short was a big winner yesterday, but I am also long Amazon and Google, which were hit with pretty strong collateral damage.

Bank Leadership Is Covering Up Some Ugly Market Issues

Bank Leadership Is Covering Up Some Ugly Market Issues

This quarter Netflix is not going to be the star of earnings season.

Stocks Drift, Oil Steadies, Dollar Dips as Investors Question Growth Prospects

Stocks Drift, Oil Steadies, Dollar Dips as Investors Question Growth Prospects

Global stocks drifted lower Tuesday, as oil prices remained in correction territory and investors re-set expectations for future U.S. rate hikes amid worrying signals from the bond market, as investors question the underlying strength of the world economy heading into the second half of the year.

Johnson & Johnson Reports 2018 Second-Quarter Results:

Johnson & Johnson Reports 2018 Second-Quarter Results:

2018 Second-Quarter Sales of $20.8 Billion Increased 10.6% versus 2017

Last Week's Market, What to Watch Now

Here’s a quick roundup of key items from last week and today as well as what we’ll be watching this week.

Johnson & Johnson Announces Quarterly Dividend For Third Quarter 2018

Johnson & Johnson Announces Quarterly Dividend For Third Quarter 2018

NEW BRUNSWICK, N.J.

Wall Street, European Stocks Edge Lower Ahead of Trump-Putin Summit in Helsinki

Wall Street, European Stocks Edge Lower Ahead of Trump-Putin Summit in Helsinki

Global stocks edged lower Monday, although investors appeared reluctant to extend gains ahead of today's summit meeting in Helsinki between U.S. President Donald Trump and Russian President Vladimir Putin.

Stocks End Slightly Higher; Indexes Post Gains For Week

Stocks End Slightly Higher; Indexes Post Gains For Week

Stocks closed modestly higher Friday with the Dow ending just above 25,000 and the S&P 500 just above 2,800.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The major U.S. indices rose on Friday, closing out the week on a two-day winning streak.

Jim Cramer: This Market Isn't Done Going Higher

Jim Cramer: This Market Isn't Done Going Higher

We aren't done moving higher even with the president ready to strike at a moment's notice against any of our allies.

Jim's Daily Rundown

Jim discusses JPMorgan and Citigroup, and also talks about Instagram and Facebook!

Johnson & Johnson Tumbles After $4.7 Billion Baby Powder-Cancer Link Verdict

Johnson & Johnson Tumbles After $4.7 Billion Baby Powder-Cancer Link Verdict

Johnson & Johnson was ordered to pay $4.69 billion to 22 women who alleged the company's talc-based products caused them to develop ovarian cancer.

JPMorgan, AT&T-Time Warner, J&J, Apple and Blue Origin - 5 Things You Must Know

JPMorgan, AT&T-Time Warner, J&J, Apple and Blue Origin - 5 Things You Must Know

U.S. stock futures rise as earnings season gets started with reports from big U.S. banks; the Justice Department appeals the approval of the AT&T-Time Warner merger; J&J is ordered to pay $4.7 billion in a talcum powder case.

Stocks Rise Modestly and 4 Other Stories to Watch Premarket Friday

Stocks Rise Modestly and 4 Other Stories to Watch Premarket Friday

Happy Friday the 13th! These are the stories moving the market ahead of today's opening bell.

Johnson & Johnson Hit by $4.7 Billion Jury Verdict in Ovarian Cancer Case

Johnson & Johnson Hit by $4.7 Billion Jury Verdict in Ovarian Cancer Case

Johnson & Johnson must pay 22 women who claimed the company's baby powder contained asbestos that gave them ovarian cancer.

St. Louis Jury Returns $4.69 Billion Verdict In First Trial Linking Baby Powder, Asbestos And Ovarian Cancer

St. Louis Jury Returns $4.69 Billion Verdict In First Trial Linking Baby Powder, Asbestos And Ovarian Cancer

ST. LOUIS, July 12, 2018 /PRNewswire/ -- A jury has awarded $4.

REPLAY: Jim Cramer on Broadcom, CA, Johnson & Johnson, Citigroup & Canopy Growth

REPLAY: Jim Cramer on Broadcom, CA, Johnson & Johnson, Citigroup & Canopy Growth

TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Thursday's trending stocks from the floor of the New York Stock Exchange

Jim Cramer: This Market Is Not as Expensive as It Looks

Jim Cramer: This Market Is Not as Expensive as It Looks

The only way the market is "dangerously elevated" is if you believe that 2019 is going to be a horrendous year.

Elliott Tackles AC Milan After Chinese Investors Falter; Pfizer Eyes Reorg-ICYMI

Elliott Tackles AC Milan After Chinese Investors Falter; Pfizer Eyes Reorg-ICYMI

Here's what you need to know now for Wednesday, July 11.

TheStreet Quant Rating: B (Buy)